Cargando…
Bayesian adaptive randomization trial of intravenous ketamine for veterans with late-life, treatment-resistant depression
More than eleven million U.S. Veterans are at least 65 years of age, an age group of which almost 20% suffers from clinically significant depressive symptoms. Available pharmacological treatments are suboptimal for patients, including veterans, with late-life depression. Ketamine has emerged as a po...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727003/ https://www.ncbi.nlm.nih.gov/pubmed/31508531 http://dx.doi.org/10.1016/j.conctc.2019.100432 |